Benzoic acid, 4-bromo-3,5-diethoxy-2-fluoro-, ethyl ester:Exports & Compliance White Paper 2026

I. Executive Summary

Ethyl 4-bromo-3,5-diethoxy-2-fluorobenzoate, CAS 2504032-48-6, is a densely functionalised aromatic building block carrying four synthetically addressable features on a single benzene ring: an aryl bromide, an ethyl ester, two ethoxy ethers and an ortho fluorine. That combination makes it a high-information-density fragment for contract development and manufacturing programmes, because each handle can be manipulated independently under conditions that leave the others intact. Material supplied into the research channel is a research and process development intermediate: it is supplied RUO, Research Use Only, has no approved therapeutic indication as supplied, and is not a finished consumer or medicinal product.

Technically, the value and the difficulty of this molecule sit in the same place: regiochemistry. Installing bromine para to the ester while the 3 and 5 positions are already ethoxy-substituted demands a carefully ordered sequence, because the two alkoxy groups are strongly activating and ortho/para-directing, and the free 4 and 6 positions differ only in their steric environment relative to the ester and the fluorine. Yield losses in practice come less from the coupling chemistry the customer later performs than from regioisomeric contamination and from partial dealkylation or ester hydrolysis during the supplier's own synthesis and workup.

Commercially in 2026 the molecule sits inside a specific regulatory conversation. A single aromatic carbon-fluorine bond is generally outside the OECD perfluoroalkyl core definition of PFAS, which turns on fully fluorinated methyl or methylene carbon atoms, yet the compound is routinely captured by buyer organofluorine questionnaires and by the structural scoping of the EPA's TSCA section 8(a)(7) PFAS reporting rule. Exporters therefore have to combine REACH and CLP position, TSCA new-chemical status, ICH Q7, Q11 and Q3D impurity discipline, and a written, defensible PFAS-position statement into one dossier.

II. Product Deep Dive: Molecular Mechanisms and Production Evolution

2.1 Physicochemical Properties and Mechanisms

The electronic picture of this ring is genuinely mixed. The two ethoxy groups donate strongly by resonance and push electron density into the 2, 4 and 6 positions, while the ester withdraws by both induction and resonance, and the fluorine withdraws inductively but donates weakly by resonance. The practical consequence is a ring that is activated toward electrophilic substitution at the remaining free positions yet electronically stabilised against nucleophilic aromatic substitution at carbon-fluorine, because there is no strong electron-withdrawing group ortho or para to it.

• Orthogonal Reactivity of the Four Handles: The aryl bromide oxidatively adds to palladium or nickel and supports Suzuki-Miyaura, Buchwald-Hartwig, Sonogashira, Miyaura borylation and cyanation chemistry. The ethyl ester is a masked carboxylic acid that survives those couplings and is hydrolysed or amidated afterwards. The ethoxy groups can be cleaved with boron tribromide or strong hydrobromic acid when the phenol is needed, and the aryl fluorine is, under these ring electronics, largely inert to substitution and functions instead as a property-modulating and conformational element.
• Conformational Consequences of the 2-Fluoro Pattern: The ortho fluorine forces the ester out of conjugation with the ring, which raises carbonyl electrophilicity relative to a planar benzoate while making the carbonyl sterically harder to attack. That twist also produces a distinctive fluorine NMR signature, which is why fluorine NMR is the preferred identity test and the most sensitive assay for regioisomeric impurity in this series.

2.2 Synthesis and Manufacturing Technologies

There is no commodity route for a molecule like this. Campaigns are built from aromatic substitution and functional-group interconversion unit operations, and the sequence order is the entire intellectual content of the process. Reputable CDMO discussion stays at the level of route class, selectivity strategy, purification and containment, never at the level of procedural facilitation.

• Regioselective Bromination and Etherification: The 3,5-diethoxy pattern is normally installed by Williamson-type ethylation of the corresponding dihydroxybenzoate using an ethylating agent such as diethyl sulfate or ethyl halide under base, with stoichiometry and phase-transfer conditions tuned to avoid mono-ethylated intermediates. Bromination is then run with a controlled electrophilic source such as N-bromosuccinimide in a polar acidic medium, and regiochemical outcome is managed through temperature, addition rate and protection of competing positions rather than through brute-force excess.
• Fluorine Installation and Esterification Strategy: Where fluorine is introduced late, classic aromatic fluorination chemistry applies, including Balz-Schiemann diazonium tetrafluoroborate thermolysis, which generates boron trifluoride and demands fluoride-compatible materials of construction and hydrogen fluoride abatement. Esterification is completed either by Fischer esterification in ethanol under acid catalysis or, more selectively, by conversion to the acid chloride with thionyl chloride or oxalyl chloride followed by ethanol quench.

2.3 Core Application Matrix

• Cross-Coupling Elaboration: The aryl bromide is the primary growth point in discovery programmes, giving biaryl, aryl amine, aryl alkyne and boronate derivatives. Bromide is often preferred over iodide here because it balances reactivity with shelf stability and lower halide cost at scale.
• Ester Manipulation and Fragment Growth: Saponification gives the substituted benzoic acid for amide coupling, while reduction to the benzyl alcohol or controlled reduction to the aldehyde opens aldehyde-based chain extension. This is the standard path from fragment to advanced intermediate.
• Analytical and Reference Standard Use: The compound is also supplied as a characterised reference or impurity standard supporting method validation, specification setting and regulatory filing in customer projects.

III. Global Market Supply-Demand Landscape and Export Trends

3.1 Demand Drivers and Market Shifts

Demand for heavily substituted fluorinated benzoates tracks the structural complexity of discovery pipelines rather than any single therapeutic area. As candidate molecules carry more sp3 character and more heteroaryl and aryl substitution, outsourced demand shifts from simple halogenated benzoic acids toward multi-functional fragments that save the customer two or three synthetic steps. That substitution effect, not volume growth, is the main commercial driver for this compound class in 2026.

3.2 Capacity Distribution and Export Flows

Supply is concentrated in the custom-synthesis belt. China provides the broadest capacity for halogenation, etherification and esterification unit operations at gram to multi-kilogram scale, typically with fast quotation cycles. India offers comparable synthetic capability with stronger English-language regulatory documentation and GMP-adjacent quality systems. European producers in Germany, Italy and Switzerland occupy the high-specification end, offering GMP campaigns and DMF-ready documentation at substantially higher unit cost.

3.3 Market Bifurcation and Pricing Dynamics

The market splits cleanly into catalogue-grade and campaign-grade material. Catalogue-grade grams are priced for convenience and speed, with a generic certificate of analysis and a small analytical set. Campaign-grade kilograms are priced on route development amortisation, purification difficulty, analytical method development and validation, elemental-impurity work and documentation, and routinely carry unit prices several times lower per gram but far higher in absolute project value.

IV. In-depth Analysis of Global Compliance and Regulatory Barriers

Three questions decide whether this building block can be shipped legally and used without downstream friction. The first is whether the substance is notified and registered where it is imported. The second is whether its impurity profile meets the pharmaceutical quality expectations of the customer programme. The third, increasingly decisive, is how its single aromatic carbon-fluorine bond is treated under PFAS-driven customer and agency screens.

4.1 European Market: REACH, CLP, and Sector-Specific Directives

• REACH Registration and the Only Representative Route: A non-EU manufacturer placing this substance on the European market above one tonne per year needs an Only Representative to hold or support the registration, and should confirm whether the substance is already registered or whether a PPORD or full registration is required before committing to a campaign. Below the tonnage threshold, the obligation shifts to knowing and documenting that status rather than to registering.
• CLP Notification and the PFAS Definition Boundary: Importers placing a hazardous substance on the market must notify classification and labelling to the C and L Inventory. On PFAS, the honest technical position is that a lone aromatic carbon-fluorine bond lacks the fully fluorinated methyl or methylene carbon that anchors the OECD perfluoroalkyl definition, so the substance generally falls outside the core PFAS definition. That does not end the enquiry: the broader universal restriction debate and customer organofluorine questionnaires often use wider triggers, so exporters should issue a written structural rationale rather than a bare yes or no.

4.2 North American Market: TSCA, EPA, and FDA Regulations

• TSCA New Chemical Status and Section 8(a)(7) Scoping: If the substance is not listed on the TSCA Inventory, import requires a premanufacture notice or a valid exemption such as the low-volume or research and development exemption with its associated notice and recordkeeping, plus the section 13 import certification. Separately, importers must assess the substance against the structural definition in the EPA's TSCA section 8(a)(7) PFAS reporting rule, whose listed substructures focus on fluorinated aliphatic carbons but whose scoping is explicitly structure-specific and should be evaluated against the current regulatory text for each consignment.
• ICH Quality Expectations for GMP Campaigns: Once the material is nominated as a registered starting material or advanced intermediate in a regulated programme, ICH Q7 good manufacturing practice for active pharmaceutical ingredients, ICH Q11 development and manufacture guidance and ICH Q3D elemental impurity assessment apply. Customers will expect a defined starting-material justification, a justified specification, and ICP-MS data on palladium, nickel, iron and other metal residues from the coupling and halogenation steps.

4.3 The Critical Hurdle: Quality Control and Safety Limits

V. Green Trade Barriers and ESG in Manufacturing

Sustainability assessment of a low-volume, high-value aromatic intermediate is not about tonnage emissions but about solvent intensity, halogenated waste and fluoride control. Buyer ESG questionnaires increasingly ask for solvent recovery rates, halide load in aqueous effluent and documented abatement of hydrogen fluoride, and ISO 14001 certification is expected of serious multi-step CDMO partners.

5.1 Carbon Footprint and Circular Economy

The carbon burden of a multi-step aromatic campaign is dominated by solvent use, solvent recovery and distillation energy, by cryogenic and heating duty across bromination, ethylation and esterification stages, and by the energy embedded in halogenated reagents. Practical improvements include solvent recovery with documented recycle ratios, telescoping steps to remove isolations, and replacing halogenated solvents where the chemistry permits.

5.2 Sustainable Sourcing and Traceability

Traceability expectations centre on reagent provenance and waste destiny. Buyers want confirmation that brominating and ethylating reagents were sourced from suppliers screened against REACH SVHC and restriction lists, that fluorination salt and hydrogen fluoride streams are handled under documented abatement, and that halogenated aqueous effluent and spent solvent are consigned to licensed treatment or recovery with auditable manifests.

VI. Supply Chain Resilience and Export Logistics

Logistics for this compound are straightforward compared with its compliance burden, but they are not trivial. The material is a crystalline organic solid whose two enemies are moisture-driven ester hydrolysis and prolonged exposure to elevated temperature during transit through hot climates.

6.1 Packaging Standards and Moisture/Contamination Control

• Moisture-Barrier Primary Packaging: Material is packed in amber glass or high-density polyethylene bottles inside moisture-barrier laminated foil pouches with desiccant and an inert nitrogen or argon headspace. Double bagging, tamper seals and lot-coded labels are standard for research-channel material, while campaign quantities move in lined fibre drums with inner polyethylene liners and desiccant.
• Temperature Management and Stability: Ambient shipment is acceptable for transit, but controlled storage at 2-8 C is recommended for long-term holding, and temperature-logged cold-chain shipment is worth the cost for multi-kilogram consignments bound for hot or humid destinations. Freeze-thaw cycling should be avoided because condensation inside the primary container drives hydrolysis.

6.2 Dangerous Goods Identification and Transit Protocols

Most shipments of this type are not assigned a UN dangerous-goods number because available hazard data does not meet transport classification criteria, and they move as general chemicals under IMDG, ADR and IATA with GHS-compliant labelling and a safety data sheet. That position must be evidenced rather than assumed: it requires a classification dossier with acute toxicity, irritation and sensitisation data or a documented read-across justification. Where any classification is assigned, packaging group, permitted quantities and documentation change immediately.

VII. Enterprise Global Expansion Strategy Guide

Suppliers that win building-block campaigns reduce the customer's development risk. The priorities below consistently separate awarded from rejected quotations for multi-functional fluorinated aromatics.

1. Sell Route Development, Not Just Material: Offer route scouting with a written freedom-to-operate review, a selectivity strategy for the bromination and ethylation steps, and an honest evaluation of whether the customer's target is better served by an alternative substitution pattern.
2. Invest in Fit-for-Purpose Analytics: Build validated HPLC and LC-MS methods, use fluorine NMR as the identity and regioisomer assay, and add ICP-MS elemental impurity screening so that ICH Q3D and genotoxic impurity questions are answered before they are asked.
3. Tier RUO and GMP Offerings Explicitly: Maintain a documented boundary between RUO-grade research supply and GMP campaign supply, with change control, starting-material justification and a tech transfer package aligned to ICH Q11, so customers can move between tiers without repeating development work.

VIII. Conclusion

Ethyl 4-bromo-3,5-diethoxy-2-fluorobenzoate is a molecule whose commercial value is entirely derived from the options it leaves open: a coupling handle, a masked acid, two cleavable ethers and a fluorine that quietly shapes conformation and downstream properties. Supplied into the research channel it is RUO material with no approved therapeutic indication as supplied, and it is not a finished consumer or medicinal product.

For CDMO suppliers in 2026, the differentiators are analytical honesty and regulatory clarity. A defensible PFAS-position statement grounded in the actual structure, documented control of hydrolysis and genotoxic impurities, ICH Q3D metal data, and a clean RUO-to-GMP tiering framework will win more programmes than price alone.

IX. Industry Resource Connection and Supplier Ecosystem

Powered by Guidechem

This white paper is exclusively compiled by the Guidechem Intelligence Team based on global customs data, regulatory databases, and industry research. Guidechem is a leading global B2B chemical platform, dedicated to connecting global buyers with verified, high-quality manufacturers.

Guidechem Global Ethyl 4-bromo-3,5-diethoxy-2-fluorobenzoate Supplier Ecosystem List

Relying on Guidechem's extensive global database, we have mapped the core participants in the current global Ethyl 4-bromo-3,5-diethoxy-2-fluorobenzoate supply chain:

• China: The broadest and fastest custom-synthesis base for halogenation, etherification and esterification unit operations, supplying catalogue grams through multi-kilogram campaigns with short quotation cycles and improving analytical documentation, particularly among producers serving export CDMO customers.
• India: Strong synthetic capability combined with English-language regulatory documentation, GMP-adjacent quality systems and experience supporting regulated-market filings, making Indian CDMOs the usual second source for customers qualifying a fluorinated aromatic building block.
• Europe: Germany, Italy and Switzerland: The high-specification end of the market, offering GMP campaigns, complete analytical packages, elemental impurity work and documentation suitable for regulatory filings, at a unit cost justified by reduced customer risk rather than by chemistry.